| 1 |
34142775 | Influences of tirofiban combined with atorvastatin on coronary blood flow restoration and changes in inflammatory factors, Cys-C, Hcy and MMP-9 in AMI patients after PCI. | 2021 Jun 18 |
1 |
| 2 |
32421147 | Statins Suppress TGF-β2-Mediated MMP-2 and MMP-9 Expression and Activation Through RhoA/ROCK Inhibition in Astrocytes of the Human Optic Nerve Head. | 2020 May 11 |
1 |
| 3 |
29312801 | Atorvastatin exhibits anti-tumorigenic and anti-metastatic effects in ovarian cancer in vitro. | 2017 |
1 |
| 4 |
26614570 | Sodium nitrite attenuates MMP-9 production by endothelial cells and may explain similar effects of atorvastatin. | 2016 Feb |
2 |
| 5 |
25595138 | Atorvastatin in combination with inhaled beclometasone modulates inflammatory sputum mediators in smokers with asthma. | 2015 Apr |
1 |
| 6 |
24397933 | Effects of atorvastatin on plasma matrix metalloproteinase-9 concentration after glial tumor resection; a randomized, double blind, placebo controlled trial. | 2014 Jan 7 |
2 |
| 7 |
24904926 | The influence of elastin degradation products, glucose and atorvastatin on metalloproteinase-1, -2, -9 and tissue inhibitor of metalloproteinases-1, -2, -3 expression in human retinal pigment epithelial cells. | 2014 |
1 |
| 8 |
23410871 | Administration of a loading dose of atorvastatin before percutaneous coronary intervention prevents inflammation and reduces myocardial injury in STEMI patients: a randomized clinical study. | 2013 Mar |
1 |
| 9 |
20888701 | Matrix metalloproteinase-9 may be a potential therapeutic target in epilepsy. | 2011 Feb |
1 |
| 10 |
21361911 | The role of atorvastatin in regulating the immune response leading to vascular damage in a model of Kawasaki disease. | 2011 May |
1 |
| 11 |
21448567 | Effects of statins on matrix metalloproteinases and their endogenous inhibitors in human endothelial cells. | 2011 Jun |
3 |
| 12 |
22088250 | [The effects of atorvastatin on C-reactive protein induced Toll-like receptor 4 expression on CD14+ monocyte]. | 2011 Jul |
3 |
| 13 |
19797126 | Statins inhibit matrix metalloproteinase release from human lung fibroblasts. | 2010 Mar |
1 |
| 14 |
20682172 | In vitro modulation of peroxisome proliferator-activated receptor-gamma and its genes by C-reactive protein. Role of atorvastatin. | 2010 Apr |
1 |
| 15 |
19082693 | Effect of atorvastatin versus rosuvastatin on levels of serum lipids, inflammatory markers and adiponectin in patients with hypercholesterolemia. | 2009 Apr |
1 |
| 16 |
18374881 | Pleiotropic effects of atorvastatin in heart failure: role in oxidative stress, inflammation, endothelial function, and exercise capacity. | 2008 Apr |
1 |
| 17 |
18572029 | Effect of intensive atorvastatin therapy on prostaglandin E2 levels and metalloproteinase-9 activity in the plasma of patients with non-ST-elevation acute coronary syndrome. | 2008 Jul 1 |
3 |
| 18 |
18638594 | Comparison effect of atorvastatin (10 versus 80 mg) on biomarkers of inflammation and oxidative stress in subjects with metabolic syndrome. | 2008 Aug 1 |
2 |
| 19 |
16938300 | Anti-inflammatory effects of atorvastatin: modulation by the T-786C polymorphism in the endothelial nitric oxide synthase gene. | 2007 Aug |
1 |
| 20 |
16490430 | Effects of rosiglitazone alone and in combination with atorvastatin on nontraditional markers of cardiovascular disease in patients with type 2 diabetes mellitus. | 2006 Mar 1 |
1 |
| 21 |
16554298 | Interleukin-18-induced human coronary artery smooth muscle cell migration is dependent on NF-kappaB- and AP-1-mediated matrix metalloproteinase-9 expression and is inhibited by atorvastatin. | 2006 Jun 2 |
1 |
| 22 |
16776933 | [The effects of 40 mg atorvastatin on serum lipids, inflammatory markers and clinical events in ACS patients post PCI]. | 2006 Apr |
2 |
| 23 |
15044331 | Atorvastatin lowers plasma matrix metalloproteinase-9 in patients with acute coronary syndrome. | 2004 Apr |
1 |
| 24 |
15093992 | Serum profiles of matrix metalloproteinases and their tissue inhibitor in patients with acute coronary syndromes. The effects of short-term atorvastatin administration. | 2004 Apr |
1 |
| 25 |
15110783 | Atorvastatin reduces CD68, FABP4, and HBP expression in oxLDL-treated human macrophages. | 2004 May 21 |
1 |
| 26 |
15247960 | Atorvastatin treatment decreases inflammatory and proteolytic activity in patients with hypercholesterolemia. | 2004 May |
4 |